⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Meta-analysis for Neurofilament Light Chain as a Biomarker in Mouse Experimental Autoimmune Encephalomyelitis Studies (S17.008)

Bernd C. Kieseier Sarah Tisserand Pamela Ramseier Tatjana Uffelmann Giuseppe Locatelli Bruno Cenni Barbara Nuesslein‐Hildesheim Marc Bigaud

View Full Paper

Ask AI

Bookmark

Share

Abstract

To assess the correlation of neurofilament light chain (NfL; potential biomarker for multiple sclerosis [MS] disease activity) in the cerebrospinal fluid (CSF)/plasma in an experimental autoimmune encephalomyelitis (EAE) mouse model.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kieseier et al. (2024) studied this question.

synapsesocial.com/papers/68e6fcc5b6db6435876773fc https://doi.org/10.1212/wnl.0000000000204745

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Serum neurofilament light chain as a biomarker of disease activity in antibody-mediated autoimmune encephalitisOriginal Research · 2026
2Neurofilament Light Chain in the Clinic: Applications and Limitations in the Management of Multiple Sclerosis (P6-18.003)Original Research · 2026
3Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management2024 · 200 citations
4Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studiesCase-Control Study · 2019 · 77 citations
5Neurofilament Light Chain in CSF and Plasma in Multiple System Atrophy – A Prospective, Longitudinal Biomarker Study (S9.003)2024